Current Oncology Reports

Papers
(The median citation count of Current Oncology Reports is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Immunotherapeutic and Targeted Strategies for Managing Brain Metastases from Common Cancer Origins: A State-of-the-Art Review149
The Value Proposition of Observation Medicine in Managing Acute Oncologic Pain145
Changing the Perspective on Fertility Preservation for Women with Metastatic or Advanced Stage Cancer99
New Developments in VHL-Associated Neuroendocrine Neoplasms98
Management of Upper Tract Urothelial Carcinoma76
NRG1 Fusions: The New Kid on the Block74
Immunotherapy in Biliary Tract Cancers: Where Are We?63
Cardiotoxic Effects Following CAR-T Cell Therapy: A Literature Review60
Advances in Targeted Therapy for Neurofibromatosis Type 2 (NF2)-Associated Vestibular Schwannomas56
Integrating Precision Medicine into the Contemporary Management of Gynecologic Cancers50
Functional Outcomes and Quality of Life in Patients with Sinonasal, Nasopharyngeal, and Anterior Skull Base Tumors46
Brain Prehabilitation for Oncologic Surgery44
Treatment of Metastatic Melanoma in the Elderly41
Surgical Management of Melanoma: Advances and Updates40
Fatty Acid Metabolism and Cancer Immunotherapy38
New Insights on Tramadol and Immunomodulation38
Shifting Epidemiology of Hepatocellular Carcinoma in Far Eastern and Southeast Asian Patients: Explanations and Implications37
Hairy Cell Leukemia (HCL) and HCL Variant: Updates and Spotlights on Therapeutic Advances37
Management of In-Transit Metastases36
Current Trends and Challenges of Microbiome Research in Prostate Cancer35
An Overview of Angiogenesis in Bladder Cancer34
Surgical Stress and Cancer Progression: New Findings and Future Perspectives33
Head and Neck Mucosal Melanoma: Where Are We Now?32
Cellular Therapy in NSCLC: Between Myth and Reality32
Opportunities and Challenges for a Histology-Agnostic Utilization of Trastuzumab Deruxtecan32
The Microbiome in Advanced Melanoma: Where Are We Now?32
The Underestimated and Overlooked Burden of Diarrhea and Constipation in Cancer Patients31
Engineered T Cells: CAR T Cell Therapy and Beyond30
Development of Delivery Systems for Local Administration of Cytokines/Cytokine Gene-Directed Therapeutics: Modern Oncologic Implications29
The Provision of Complementary, Alternative, and Integrative Medicine Information and Services: a Review of World Leading Oncology Hospital Websites29
“What Should I Eat?”—Addressing Questions and Challenges Related to Nutrition in the Integrative Oncology Setting29
The Difficult Airway in Patients with Cancer28
Anti-PD-1: When to Stop Treatment27
AXL Inhibitors: Status of Clinical Development27
How Have Targeted Agents Changed the Treatment Landscape for Elderly Patients with CLL?26
An Integrated Care Approach to Improve Well-Being in Breast Cancer Patients26
Breast cancer Treatment and Fertility Preservation: A Narrative Review of Impacts, Strategies and Ethical Considerations26
Primary or Interval Debulking Surgery in Advanced Ovarian Cancer: a Personalized Decision—a Literature Review26
Cancer Pain Management—New Therapies26
Appendiceal Neuroendocrine Neoplasms: an Update for 202325
Novel Surgical Initiatives in Gastroenteropancreatic Neuroendocrine Tumours25
Targeting the PI3K Pathway in Gynecologic Malignancies25
Proton Therapy in The Treatment of Head And Neck Cancers- Review25
Current Approaches in Hepatoblastoma—New Biological Insights to Inform Therapy24
What Is the Status of Immunotherapy in Neuroendocrine Neoplasms?24
CAR-T Therapies in Solid Tumors: Opportunities and Challenges24
Current Status of Stem Cell Transplant in Treatment of Testicular Germ Cell Tumors24
Diagnostic Accuracy of Liquid Biopsy for Oral Potentially Malignant Disorders and Head and Neck Cancer: an Overview of Systematic Reviews23
Surgical Management of the Primary Tumor in Stage IV Small Intestinal Neuroendocrine Tumors: To Operate or Not to Operate, That Is the Question22
Surgery for Recurrent Epithelial Ovarian Cancer22
Evolving Role of CAR T Cell Therapy in First- and Second-Line Treatment of Large B Cell Lymphoma22
Current Management of Neuroendocrine Tumour Liver Metastases22
Pitfalls and Successes in Trials in Older Transplant Patients with Hematologic Malignancies22
Treatments on the Horizon: Breast Cancer Patients with Central Nervous System Metastases22
Use of Circulating Tumor DNA to Guide Decision-making in Adjuvant Colon Cancer22
Pre- and Post-Microsurgical Rehabilitation Interventions and Outcomes on Breast Cancer–Related Lymphedema: a Systematic Review21
Critical Review of the Current Evidence on Sentinel Node Biopsy in Oral Cancer20
Antibody-Drug Conjugates in Breast Cancer: The Road Towards Biologically-Informed Selection and Sequencing20
Helping Patients Understand and Cope with BRCA Mutations20
Biomarkers in the Immuno-oncology Interface of Triple Negative Breast Cancer: A Scoping Review with Perioperative Considerations20
Development of Effective Siglec-9 Antibodies Against Cancer20
A Systematic Review and a Meta-analysis of Randomized Controlled Trials’ Control Groups in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)20
Geographical Disparities in Colorectal Cancer in Canada: A Review20
Evolving Treatment Approaches to Mucosal Melanoma20
Vascular Inflammation, Cancer, and Cardiovascular Diseases19
Controversies in the Treatment of Adolescents and Young Adults with Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia19
Inequities Among Cancer Caregivers with Diverse Identities: A Review of the Literature and Future Directions19
Role of the Microbiome and Diet for Response to Cancer Checkpoint Immunotherapy: A Narrative Review of Clinical Trials19
Small Cell and Other Rare Histologic Types of Cervical Cancer18
Cardioprotection for Anti-HER2 Therapy: Considerations for Primary Prevention and Use in Mildly Reduced Left Ventricular Ejection Fraction18
Is PD-1 Inhibitor Monotherapy a New Standard Treatment for MMR-Deficient Locally Advanced Rectal Cancer?18
Dedifferentiated Chondrosarcoma: Diagnostic Controversies and Emerging Therapeutic Targets18
Current Diagnostic Tools for Breast Cancer-Related Lymphedema18
Elderly Rectal Cancer: An Updated Review17
Management of Peripheral T-cell Lymphomas and the Role of Transplant17
Chronic Lymphocytic Leukemia in the SARS-CoV-2 Pandemic17
Ependymoma: Evaluation and Management Updates17
Rehabilitation in Advanced Cancer Patients with Bone Metastases and Neural Compromise: Current Status and Future Directions17
The Evidence for Using Artificial Intelligence to Enhance Prostate Cancer MR Imaging17
Therapeutic Management in Elderly Male Breast Cancer Patients: A Scoping Review17
Advancements in the Diagnosis, Treatment, and Risk Stratification of Non-Muscle Invasive Bladder Cancer17
Emerging Disparities in Prevention and Survival Outcomes for Patients with Head and Neck Cancer and Recommendations for Health Equity17
History of Leukemia, Revisited16
Epidemiology of Cancer in Older Adults: A Systematic Review16
Immunological Insights into Opioid-Free Anaesthesia in Oncological Surgery: A Scoping Review16
Intratumoral Immunotherapy: Is It Ready for Prime Time?16
Multimodality Therapies for Localized Prostate Cancer16
Integrative Medicine Across the Pediatric Cancer Care Trajectory: A Narrative Review16
Current Status on Management of Primary Plasma Cell Leukemia16
Statins for Cardiac and Vascular Protection During and After Cancer Therapy16
Human Epidermal Growth Factor Receptor 2 Positive Advanced Gastric or Esophagogastric Adenocarcinoma: Reflecting on the Past to Gain a New Insights16
Integrative Oncology Approaches to Supporting Immune Checkpoint Inhibitor Treatment of Solid Tumours15
Management of Pathologic Node-Positive Prostate Cancer following Radical Prostatectomy15
Unveiling the Hidden Links: Periodontal Disease, Fusobacterium Nucleatum, and Cancers15
Cardiovascular Effects of Immune Checkpoint Inhibitors: More Than Just Myocarditis15
Limb Amputations in Cancer: Modern Perspectives, Outcomes, and Alternatives15
Molecular Biomarkers in Sinonasal Cancers: New Frontiers in Diagnosis and Treatment15
Treatment Approaches for Melanomas That Relapse After Adjuvant or Neoadjuvant Therapy15
Clonal Hematopoiesis of Indeterminate Potential: Current Understanding and Future Directions14
Blood–Brain Barrier Disruption for the Treatment of Primary Brain Tumors: Advances in the Past Half-Decade14
Cured or Not? Long-term Outcomes of Immunotherapy Responders. Focus on Melanoma14
Fluoropyrimidine Cardiotoxicity: Incidence, Outcomes, and Safety of Rechallenge14
Targeting The Tumor Microenvironment in Lymphomas: Emerging Biological Insights and Therapeutic Strategies14
Richter’s Transformation14
Nectin-4: a Tumor Cell Target and Status of Inhibitor Development14
Return to Intended Oncological Therapy: State of the Art and Perspectives14
Bystander effect of antibody–drug conjugates: fact or fiction?14
Nasal Cavity and Paranasal Sinus Cancer: Diagnosis and Treatment14
Viral and Clinical Oncology of Head and Neck Cancers13
The Role and Impact of Minimal Residual Disease in NSCLC13
Racial Disparities in Breast Cancer: from Detection to Treatment13
Cardio-Oncology in Childhood: State of the Art13
Cerebrospinal Fluid Liquid Biopsies in the Evaluation of Adult Gliomas13
15 Years Old ALK Gene from Birth to Adolescence; Where to in NBL13
Current Approaches to Neoadjuvant Immunotherapy in Resectable Non-small Cell Lung Cancer13
All-Cause Mortality Risk Prediction in Older Adults with Cancer: Practical Approaches and Limitations13
Prevention of Ovarian Cancer: Where are We Now and Where are We Going?13
Interventional Strategies in Cancer-induced Cardiovascular Disease13
Is Myelodysplasia a Consequence of Normal Aging?13
CDK4/6 inhibitors: The Devil is in the Detail13
Lymphatic Interventions in the Cancer Patient13
CAR T-cell Therapy for Central Nervous System Lymphoma12
Resectability versus Operability in Early-Stage Non-Small Cell Lung Cancer12
Integration of Liquid Biopsies in Clinical Management of Metastatic Prostate Cancer12
Surviving Burnout as an Oncologist12
Cardiovascular Toxicity of Novel HER2-Targeted Therapies in the Treatment of Breast Cancer12
Clinicopathological Review of Micropapillary Urothelial Carcinoma12
Advances in Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer12
Radiogenomics as an Integrated Approach to Glioblastoma Precision Medicine12
Advances in Treatment of Waldenström Macroglobulinemia12
Tivozanib Monotherapy in the Frontline Setting for Patients with Metastatic Renal Cell Carcinoma and Favorable Prognosis12
Lymphatic Mapping and Sentinel Node Biopsy in High-Grade Uterine Cancers12
Current Role of Functional Imaging in the Management of Lymphoma12
Oral Health in Patients with History of Head and Neck Cancer: Complexity and Benefits of a Targeted Oral Healthcare Pathway12
Traditional Chinese Medicine Herbs for Breast Cancer Prevention and Survival: A Narrative Review of Epidemiological Studies from Taiwan12
Treatment of Primary CNS Lymphoma: Maximizing Clinical Benefit, Minimizing Neurotoxicity12
Epidemiology of cancer in older adults: a systematic review of age-related differences in solid malignancies treatment12
Correction: Enhanced Recovery in Gynecologic Oncology Surgery—State of the Science12
Options for Rescue Treatment of Patients with AL Amyloidosis Exposed to Upfront Daratumumab11
Combination Therapy in Renal Cell Carcinoma: the Best Choice for Every Patient?11
Chronodisruption and Ambulatory Circadian Monitoring in Cancer Patients: Beyond the Body Clock11
Current Issues in Treatment of Parotid Gland Cancer and Advanced Surgical Technique of Robotic Parotidectomy11
Perioperative Blood Transfusions and Cancer Progression: A Narrative Review11
Integrative Geriatric Oncology: A Review of Current Practices11
Rehabilitation Needs for Patients Undergoing CAR T-Cell Therapy11
Fertility-Sparing and Less Radical Surgery for Cervical Cancer11
Pelvic Floor Therapy and Initial Interventions for Pelvic Floor Dysfunction in Gynecologic Malignancies11
BTK Inhibitors and CAR T-Cell Therapy in Treating Mantle Cell Lymphoma—Finding a Dancing Partner11
State of Rehabilitation Research in the Head and Neck Cancer Population: Functional Impact vs. Impairment-Focused Outcomes11
Direct Oral Anticoagulants for Cancer-Associated Venous Thromboembolism11
Use of Antihyperglycemic Drugs and Risk of Cancer in Patients with Diabetes11
Next-Generation Immunotherapy Approaches in Melanoma11
Percutaneous Ablation of T1b Renal Cell Carcinoma: An Overview11
Cold-antibody Autoimmune Hemolytic Anemia: its Association with Neoplastic Disease and Impact on Therapy10
Intracranial Germinomas: Diagnosis, Pathogenesis, Clinical Presentation, and Management10
Clinical Applications and Advancements of Positron Emission Tomography/Computed Tomography in Cardio-Oncology: A Comprehensive Literature Review and Emerging Perspectives10
COVID-19 in Children with Cancer10
Defining The Role for Hormone Therapy in Biochemically Recurrent Prostate Cancer: What Counts as a Win for Patients?10
New Developments in Image-Guided Percutaneous Irreversible Electroporation of Solid Tumors10
Adjuvant Therapy in Node-Positive Endometrial Cancer: A Focus on Chemotherapy10
Post-acute Care Needs and Benefits of Inpatient Rehabilitation Care for the Oncology Patient10
Exercise as Medicine in Cardio-Oncology: Reducing Health Disparities in Hispanic and Latina Breast Cancer Survivors10
Correction to: Postmastectomy Functional Impairments10
Optimizing Care: Integrative Oncology in Myeloproliferative Neoplasm10
Locoregional Therapy in the Management of Intrahepatic Cholangiocarcinoma: Is There Sufficient Evidence to Guide Current Clinical Practice?10
Oral Complications and Management Strategies for Cancer Patients: Principles of Supportive Oncology in Dentistry9
The Microbiome’s Influence on Head and Neck Cancers9
Enhanced Recovery in Gynecologic Oncology Surgery—State of the Science9
Perceptions, Knowledge, and Attitudes of General Population About Prostate Cancer-Associated Risk Factors: A Systematic Review of Qualitative Studies Focusing on Lifestyle9
Perioperative NSAIDs and Long-Term Outcomes After cancer Surgery: a Systematic Review and Meta-analysis9
Targeting Apoptosis in Cancer9
Germline Mutations and Ancestry in Prostate Cancer9
Asparaginase: How to Better Manage Toxicities in Adults9
Prostate Cancer, Pathophysiology and Recent Developments in Management: A Narrative Review9
Managing Pain and Discomfort in Children with Cancer9
Disparities in Lung Cancer Treatment9
The Future Glioblastoma Clinical Trials Landscape: Early Phase 0, Window of Opportunity, and Adaptive Phase I–III Studies9
Oligometastatic Esophagogastric Cancer: Does It Exist and How Do We Treat It?9
BCR/ABL-Positive Chronic Myeloid Leukemia in Children: Current Treatment Approach9
Toxicities from BRAF and MEK Inhibitors: Strategies to Maximize Therapeutic Success9
An Update in Anticoagulant Therapy for Patients with Cancer-Associated Venous Thromboembolism9
Current Status of Perioperative Therapy in Muscle-Invasive Bladder Cancer and Future Directions9
Beyond Immune Checkpoint Inhibitors: Emerging Targets in Melanoma Therapy8
Melanoma in Pediatric and Young Adult Patients8
ChatGPT in Oncology Diagnosis and Treatment: Applications, Legal and Ethical Challenges8
Advances in Radionuclide Therapies for Patients with Neuro-endocrine Tumors8
Cyclin-dependent Kinases 4/6 Inhibitors in Neuroendocrine Neoplasms: from Bench to Bedside8
Approach to Oligometastatic Cancer in the Elderly Patient8
Systematic Reviews and Meta-Analyses of Portal Vein Embolization, Associated Liver Partition and Portal Vein Ligation, and Radiation Lobectomy Outcomes in Hepatocellular Carcinoma Patients8
Genomic Landscape of Pleural Mesothelioma and Therapeutic Aftermaths8
Hairy Cell Leukemia: Where Are We in 2023?8
Cell-free Tumor DNA: a Promising Technology for Diagnosis, Surveillance and Therapeutic Decision in Urothelial Carcinoma of the Bladder8
Integrative Oncology Approaches to Reduce Recurrence of Disease and Improve Survival8
Targeted Therapy for Melanomas Without BRAF V600 Mutation8
The Role of Hyperthermia in the Treatment of Peritoneal Surface Malignancies8
Evolving Strategies in the Management of Microsatellite Instability-High/Mismatch Repair Deficient Esophagogastric Adenocarcinoma8
Novel Insights of Anti-EGFR Therapy in HNSCC: Combined with Immunotherapy or Not?8
25 Years of Adjuvant Therapy in Melanoma: A Perspective on Current Approvals and Insights into Future Directions8
Beneath the Surface: The Emerging Role of Ultra-Processed Foods in Obesity-Related Cancer8
Molecular Subgroups of Diffuse Large B Cell Lymphoma: Biology and Implications for Clinical Practice8
Radiation and Melanoma: Where Are We Now?8
Correction to: Past, Present, and Future Therapeutic Strategies for NF‑1‑Associated Tumors8
Cardiovascular Disease in Adult Cancer Survivors: a Review of Current Evidence, Strategies for Prevention and Management, and Future Directions for Cardio-oncology8
Effect of Post-diagnosis Physical Activity on Breast Cancer Recurrence: a Systematic Review and Meta-analysis8
Palliative Care in Paediatric Oncology: an Update7
Update on Percutaneous Ablation for Sarcoma7
Novel Therapies for High-Risk Non-Muscle Invasive Bladder Cancer7
Lung Neuroendocrine Tumors: How Does Molecular Profiling Help?7
Combined BRAF-Targeted Therapy with Immunotherapy in BRAF-Mutated Advanced Melanoma Patients7
Epigenetic Role of Long Non-coding RNAs in Multiple Myeloma7
Management of Recurrent HPV-Positive Oropharyngeal Squamous Cell Carcinoma: a Contemporary Review7
Postoperative Delirium and Neurocognitive Disorders: Updates for Providers Caring for Cancer Patients7
Liver Cancer Etiology: Old Issues and New Perspectives7
Recent Progress in Mind–Body Therapies in Cancer Care7
Radiation-Induced Cardiovascular Disease: Mechanisms, Prevention, and Treatment7
Bruton’s tyrosine kinase Inhibitors and Cardiotoxicity: More Than Just Atrial Fibrillation7
Current Issues in Fertility Preservation Among Pediatric and Adolescent Cancer Patients7
Early Therapeutic Interventions for Newly Diagnosed Glioblastoma: Rationale and Review of the Literature7
Prostate Cancer in Transgender Women: Epidemiology, Clinical Characteristics, and Management Challenges7
Integration of Postoperative Radiation Therapy with Cyclin-Dependent Kinase (CDK) Inhibitors7
Chemokine Receptor Antagonists: Role in Oncology7
Cardiac Arrhythmias in Oncological Patients—Epidemiology, Risk Factors, and Management within the Context of the New ESC 2022 Guidelines7
Next-Generation Sequencing—Optimal Sequencing of Therapies in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)7
Older Patients with Lung Cancer: a Summary of Seminal Contributions to Optimal Patient Care7
Cardiovascular Toxicity and Risk Mitigation with Lung Cancer Treatment6
Mixed Phenotype/Lineage Leukemia: Has Anything Changed for 2021 on Diagnosis, Classification, and Treatment?6
Molecular Testing in Gliomas: What is Necessary in Routine Clinical Practice?6
Immune Checkpoint Inhibitors in Geriatric Oncology6
De-escalation for Human Papillomavirus-Positive Oropharyngeal Cancer: A Look at the Prospective Evidence6
Managing Metastatic Extrapulmonary Neuroendocrine Carcinoma After First-Line Treatment6
Easing the Journey—an Updated Review of Palliative Care for the Patient with High-Grade Glioma6
Immune Checkpoint Inhibitors in the Aged6
Enhanced Recovery After Surgery (ERAS) in Surgical Oncology6
Cancer Predisposition Genes in Adolescents and Young Adults (AYAs): a Review Paper from the Italian AYA Working Group6
Systemic Therapy for Non-Melanoma Skin Cancers: Latest Advances6
Optimal Use of Tumor-Based Molecular Assays for Localized Prostate Cancer6
Emerging Therapeutic Targets of Neuroendocrine Prostate Cancer6
Existing Health Inequities in the Treatment of Advanced and Metastatic Cancers6
Novel Clinical PET Tracers in the Pipeline for Melanoma6
Cardiotoxicities of Non-Chemotherapeutic Metastatic Breast Cancer Treatments6
Metronomic Chemotherapy in Elderly Patients6
Aromatase Inhibitor Musculoskeletal Syndrome and Bone Loss: a Review of the Current Literature6
Immunotherapy Versus Hospice: Treatment Decision-Making in the Modern Era of Novel Cancer Therapies6
Percutaneous Management of Breast Cancer: a Systematic Review6
Lymphoblastic Lymphoma: a Concise Review6
Immune-Related Adverse Events in Patients with Lung Cancer6
Ablation of Kidney Tumors in Patients with Substantial Kidney Impairment: Current Status6
Current Trends and Challenges of Microbiome Research in Bladder Cancer6
Non-squamous Cancers of the Larynx6
Male Breast Cancer: a Review on Diagnosis, Treatment, and Survivorship6
0.054816007614136